Recombinant poxvirus

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 7384643
APP PUB NO 20040142002A1
SERIAL NO

10781262

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Use for novel chemokine-binding protein designated A41L, and chemokine-binding fragments thereof, for the treatment of conditions such as inflammation. The A41L protein binds to chemokines in the CXC group.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
OXXON THERAPEUTICS LIMITED25 MILTON PARK 2ND FLOOR PARK GATE OXFORD OX14 4SH

International Classification(s)

  • Non-US Classification not provided for expired patents

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ng, Aylwin Singapore, SG 6 17
Smith, Geoffrey Oxford, GB 34 577

Cited Art Landscape

Load Citation

Patent Citation Ranking

  • Citation Ranking not provided for expired patents

Forward Cite Landscape

Load Citation